tiprankstipranks
Trending News
More News >
Oragenics Inc (OGEN)
:OGEN
US Market

Oragenics (OGEN) Income Statement

Compare
1,054 Followers

Oragenics Income Statement

Last quarter (Q3 2025), Oragenics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Oragenics's net income was $-3.07M. See Oragenics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -22.11M
Operating Expenses
$ 10.56M$ 20.90M$ 14.42M$ 15.77M$ 4.53M
Depreciation and Amortization
$ 0.00$ 27.39K$ 44.67K$ 41.24K$ 51.70K
EBITDA
$ -10.54M$ -20.60M$ -14.23M$ -15.65M$ -26.59M
Operating Income
$ -10.56M$ -20.90M$ -14.42M$ -15.77M$ -26.64M
Other Income/Expenses
$ -9.10K$ 249.17K$ 132.38K$ 59.40K$ 210.76K
Pretax Income
$ -10.57M$ -20.66M$ -14.29M$ -15.71M$ -26.43M
Net Income
$ -10.57M$ -20.66M$ -14.29M$ -15.71M$ -26.43M
Per Share Metrics
Basic EPS
$ -1.60$ -9.18$ -7.11$ -8.09$ -28.05
Diluted EPS
$ -1.60$ -9.18$ -7.11$ -8.09$ -28.05
Weighted Average Shares Outstanding
6.62M 2.25M 2.01M 1.88M 942.19K
Weighted Average Shares Outstanding (Diluted)
6.62M 2.25M 2.01M 1.88M 942.19K
Currency in USD

Oragenics Earnings and Revenue History